Home Interviews BioStock Studio: CLS’ CEO about Q3 and the road ahead

BioStock Studio: CLS’ CEO about Q3 and the road ahead

YouTube video

BioStock Studio: CLS’ CEO about Q3 and the road ahead

22 November, 2021

At the end of last week, Lundbased medtech company Clinical Laserthermia Systems, CLS, published its report for the third quarter 2021. The company’s CEO Dan Mogren came to BioStock’s studio to tell us more about the most important events of the past quarter and what lies ahead for CLS.

See the full interview with CLS CEO Dan Mogren below.

YouTube video

 

 

The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.

Prenumerera på BioStocks nyhetsbrev